{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:24:42Z","timestamp":1787505882235,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/md.0000000000001796","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T08:48:26Z","timestamp":1445676506000},"page":"e1796","source":"Crossref","is-referenced-by-count":41,"title":["Adult Living Donor Liver Transplantation Across ABO-Incompatibility"],"prefix":"10.1097","volume":"94","author":[{"given":"Chen-Fang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsien","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruey-Shyang","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Shiue","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Jung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Song","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-62-20210309","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1600-6143.2010.03021.x","article-title":"Trends in organ donation and transplantation in the United States, 1999-2008.","volume":"10","author":"Wolfe","year":"2010","journal-title":"Am J Transplant"},{"key":"R2-62-20210309","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0029-1192060","article-title":"Evolving surgical approaches in liver transplantation.","volume":"29","author":"Petrowsky","year":"2009","journal-title":"Semin Liver Dis"},{"key":"R3-62-20210309","first-page":"31","article-title":"ABO-incompatible liver transplant: is it justifiable Liver T","volume":"9","author":"Stegall","year":"2003","journal-title":"ranspl"},{"key":"R4-62-20210309","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jlts.2003.50011","article-title":"ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation.","volume":"9","author":"Hunto","year":"2003","journal-title":"Liver Transpl"},{"key":"R5-62-20210309","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.20816","article-title":"Adult liver transplantation using live ABO-incompatible grafts in Western countries.","volume":"12","author":"Sugawara","year":"2006","journal-title":"Liver Transpl"},{"key":"R6-62-20210309","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.20652","article-title":"Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.","volume":"12","author":"Haga","year":"2006","journal-title":"Liver Transpl"},{"key":"R7-62-20210309","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan.","volume":"47","author":"Egawa","year":"2008","journal-title":"Hepatology"},{"key":"R8-62-20210309","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.TP.0000110295.88926.5C","article-title":"Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation.","volume":"77","author":"Egawa","year":"2004","journal-title":"Transplantation"},{"key":"R9-62-20210309","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/ajt.12520","article-title":"Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.","volume":"14","author":"Egawa","year":"2014","journal-title":"Am J Transpl"},{"key":"R10-62-20210309","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s10620-008-0618-y","article-title":"Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT.","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R11-62-20210309","doi-asserted-by":"crossref","first-page":"759581","DOI":"10.1155\/2009\/759581","article-title":"Adult living donor liver transplantation with ABO-incompatible grafts: a German single center experience.","volume":"2009","author":"Goralczyk","year":"2009","journal-title":"J Transplant"},{"key":"R12-62-20210309","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.transci.2009.05.012","article-title":"Isoagglutinin titre adsorption: breaking the barrier in major AB0-incompatible organ transplantation.","volume":"41","author":"Wilde","year":"2009","journal-title":"Transfus Apheresis Sci"},{"key":"R13-62-20210309","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s00268-014-2667-z","article-title":"Clinical strategy for the reconstruction of middle hepatic vein tributaries in right liver living donor liver transplantation.","volume":"38","author":"Chan","year":"2014","journal-title":"World J Surg"},{"key":"R14-62-20210309","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00007890-199902270-00014","article-title":"Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection.","volume":"67","author":"Kasahara","year":"1999","journal-title":"Transplantation"},{"key":"R15-62-20210309","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/TP.0b013e318208138c","article-title":"Clinical perspective of acute humoral rejection after blood type-compatible liver transplantation.","volume":"91","author":"Chan","year":"2011","journal-title":"Transplantation"},{"key":"R16-62-20210309","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/lt.20727","article-title":"ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy.","volume":"12","author":"Troisi","year":"2006","journal-title":"Liver Transpl"},{"key":"R17-62-20210309","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2013.07.035","article-title":"ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor.","volume":"59","author":"Kim","year":"2013","journal-title":"J Hepatol"},{"key":"R18-62-20210309","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transci.2009.10.013","article-title":"ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.","volume":"42","author":"Josephson","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"R19-62-20210309","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.transproceed.2005.03.148","article-title":"New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.","volume":"37","author":"Yoshizawa","year":"2005","journal-title":"Transplant Proc"},{"key":"R20-62-20210309","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00268-003-7263-6","article-title":"Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts.","volume":"28","author":"Shimazu","year":"2004","journal-title":"World J Surg"},{"key":"R21-62-20210309","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3181adcae6","article-title":"Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO-incompatible living donor liver transplantation.","volume":"88","author":"Ikegami","year":"2009","journal-title":"Transplantation"},{"issue":"Suppl 8","key":"R22-62-20210309","doi-asserted-by":"crossref","first-page":"s59","DOI":"10.1097\/01.tp.0000446279.81922.dd","article-title":"A desensitizing protocol without local graft infusion therapy and splenectomy is a safe and effective method in abo-incompatible adult LDLT.","volume":"97","author":"Song","year":"2014","journal-title":"Transplantation"},{"key":"R23-62-20210309","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/lt.21092","article-title":"B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.","volume":"13","author":"Egawa","year":"2007","journal-title":"Liver Transpl"},{"key":"R24-62-20210309","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1525-1594.2000.06490.x","article-title":"Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption.","volume":"24","author":"Matic","year":"2000","journal-title":"Artif Organs"},{"key":"R25-62-20210309","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1034\/j.1399-0012.1999.130503.x","article-title":"Functional, life-threatening disorders and splenectomy following liver transplantation.","volume":"13","author":"Troisia","year":"1999","journal-title":"Clin Transplant"},{"key":"R26-62-20210309","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2141.2009.07718.x","article-title":"Rituximab in non-haematological disorders of adults and its mode of action.","volume":"146","author":"McDonald","year":"2009","journal-title":"Br J Haematol"},{"key":"R27-62-20210309","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.TP.0000149337.40911.E4","article-title":"Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation.","volume":"79","author":"Usuda","year":"2005","journal-title":"Transplantation"},{"key":"R28-62-20210309","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00007890-200207150-00014","article-title":"Rn, Loyd Je, Goodwin A, et al. Successful management of an abo-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy.","volume":"74","year":"2002","journal-title":"Transplantation"},{"key":"R29-62-20210309","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1034\/j.1600-6143.2003.00180.x","article-title":"Overcoming a positive crossmatch in living-donor kidney transplantation.","volume":"3","author":"Gloora","year":"2003","journal-title":"Am J Transplant"},{"key":"R30-62-20210309","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0003-4975(02)03824-9","article-title":"Treatment of humoral rejection with rituximab.","volume":"74","author":"Garrett","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"R31-62-20210309","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-0012.2006.00572.x","article-title":"Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.","volume":"21","author":"Usui","year":"2007","journal-title":"Clin Transplant"},{"key":"R32-62-20210309","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000658-199308000-00006","article-title":"Increased bile duct complications in liver transplantation across the ABO barrier.","volume":"218","author":"Sanchez-Urdazpal","year":"1993","journal-title":"Ann Surg"},{"key":"R33-62-20210309","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"R34-62-20210309","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production.","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"R35-62-20210309","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.transproceed.2008.10.073","article-title":"Proteasome inhibition reduces donor-specific antibody levels.","volume":"41","author":"Everly","year":"2009","journal-title":"Transplant Proc"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:52:07Z","timestamp":1620946327000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201510030-00062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":35,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001796","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}